[Maxillary osteonecrosis associated with the use of zoledronate: Presentation of three cases].
Elisenda Bolívar
EB
Puigoriol
Núria Camprodon
NC
Tuneu
Cristina Farriols
CF
Danés
José Planas
JP
Domingo
D000368:Aged; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008297:Male; D008439:Maxillary Diseases / Q000139:chemically induced*; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced*; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid